Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477252PMC
http://dx.doi.org/10.1136/bcr-2021-244301DOI Listing

Publication Analysis

Top Keywords

reversible corticosubcortical
4
corticosubcortical flair
4
flair hypointensity
4
hypointensity transient
4
transient focal
4
focal neurological
4
neurological episode
4
reversible
1
flair
1
hypointensity
1

Similar Publications

Article Synopsis
  • Porphyria is a rare disorder that affects heme metabolism, leading to various symptoms, including abdominal pain, vomiting, and seizures.
  • A clinical case of a 29-year-old man highlights the importance of diagnostic imaging (CT and MRI), which revealed parieto-occipital involvement and confirmed porphyria through lab tests.
  • Acute porphyria attacks should be considered in young patients presenting with seizures and abdominal pain, especially when typical causes of posterior reversible encephalopathy syndrome (PRES) are absent.
View Article and Find Full Text PDF

Background: Reversible loss of consciousness is the primary therapeutic endpoint of general anesthesia; however, the drug-invariant mechanisms underlying anesthetic-induced unconsciousness are still unclear. This study aimed to investigate the static, dynamic, topological and organizational changes in functional brain network induced by five clinically-used general anesthetics in the rat brain.

Method: Male Sprague-Dawley rats (n = 57) were randomly allocated to received propofol, isoflurane, ketamine, dexmedetomidine, or combined isoflurane plus dexmedetomidine anesthesia.

View Article and Find Full Text PDF

Posterior Reversible Encephalopathy Syndrome (PRES) is a radio-clinical entity associating reversible damage of the central nervous system and typical brain imaging. The clinical context is often suggestive with, in half of cases, the use of vasoactive substances (cannabis, antidepressants, nasal decongestants) and/or postpartum. The etiologies are dominated by hypertensive encephalopathy, preeclampsia, eclampsia, immunosuppressive therapies, and systemic diseases.

View Article and Find Full Text PDF

COVID-19-related posterior reversible encephalopathy syndrome: insights from a clinical case.

Encephalitis

January 2024

Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, Tübingen, Germany.

In the present case report, a 50-year-old female presented with hemiparesis and blurred vision and was subsequently diagnosed with posterior reversible encephalopathy syndrome (PRES) associated with coronavirus disease 2019 (COVID-19). Magnetic resonance imaging revealed cortico-subcortical edema with hyperintensities bilaterally in the frontoparietal and bi-occipital regions. Although PRES is a neurotoxic disorder that typically affects white matter of the brain and often is associated with hypertension, renal failure, and autoimmune disorders, recent studies have suggested that COVID-19 increases the risk of PRES.

View Article and Find Full Text PDF

Background: Brain abnormalities are a concern in COVID-19, so we used minimally invasive autopsy (MIA) to investigate it, consisting of brain 7T MR and CT images and tissue sampling via transethmoidal route with at least three fragments: the first one for reverse transcription polymerase chain reaction (RT-PCR) analysis and the remaining fixed and stained with hematoxylin and eosin. Two mouse monoclonal anti-coronavirus (SARS-CoV-2) antibodies were employed in immunohistochemical (IHC) reactions.

Results: Seven deceased COVID-19 patients underwent MIA with brain MR and CT images, six of them with tissue sampling.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!